# Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice

> **NCT01793142** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 3430 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Viviant

## Key facts

- **NCT ID:** NCT01793142
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-24
- **Primary completion:** 2017-05-31
- **Final completion:** 2017-05-31
- **Target enrollment:** 3430 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793142, "Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual Practice". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT01793142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*